{
    "nctId": "NCT01612728",
    "briefTitle": "Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast Cancer",
    "officialTitle": "Aromatase Inhibitor-Induced Arthralgia: A Proposed Management Algorithm",
    "overallStatus": "WITHDRAWN",
    "conditions": "Breast Cancer, Arthralgia, Joint Pain",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Medication compliance",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* age greater than 18 years\n* stage I-III ER+ breast cancer\n* beginning adjuvant AI therapy\n* post-menopausal as defined by any of the following: age \\>60 years, history of bilateral oophorectomy, amenorrhea for 1 year with intact uterus and ovaries, or serum estradiol and FSH concentrations in the post-menopausal range along with either amenorrhea for 6 months or previous hysterectomy\n\nExclusion Criteria:\n\n* previous use of an aromatase inhibitor",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}